UK markets open in 1 hour 12 minutes

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.8200+0.0200 (+0.71%)
At close: 04:00PM EDT
2.8500 +0.03 (+1.06%)
After hours: 06:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
31,420
31,420
22,870
4,852
295.15
Selling general and administrative
8,084
8,084
5,359
5,253
2,140
Total operating expenses
39,504
39,504
28,229
10,105
2,435
Operating income or loss
-39,504
-39,504
-28,229
-10,105
-2,435
Interest expense
-
-
-
2.414
1,453
Total other income/expenses net
-239.216
-239.216
-194.709
1,591
-
Income before tax
-39,244
-39,244
-28,241
-8,516
-3,783
Income tax expense
16.949
16.949
20.777
6.004
0.8
Income from continuing operations
-39,261
-39,261
-28,261
-8,522
-3,783
Net income
-39,261
-39,261
-28,261
-8,522
-3,783
Net income available to common shareholders
-39,261
-39,261
-28,261
-8,522
-3,783
Basic EPS
-1.68
-
-1.45
-0.58
-1.24
Diluted EPS
-1.68
-
-1.45
-0.58
-1.24
Basic average shares
22,545
-
19,516
14,791
3,062
Diluted average shares
22,545
-
19,516
14,791
3,062